The effects of non-compliance on intent-to-treat analysis of equivalence trials

被引:28
作者
Sheng, D
Kim, MY
机构
[1] NYU, Dept Environm Med, Sch Med, Div Biostat, New York, NY 10016 USA
[2] Albert Einstein Coll Med, Div Biostat, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
关键词
non-compliance; equivalence trials; non-inferiority trials; intent-to-treat;
D O I
10.1002/sim.2230
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The standard approach for analysing a randomized clinical trial is based on intent-to-treat (ITT) where subjects are analysed according to their assigned treatment group regardless of actual adherence to the treatment protocol. For therapeutic equivalence trials, it is a common concern that an ITT analysis increases the chance of erroneously concluding equivalence. In this paper, we formally investigate the impact of non-compliance on an ITT analysis of equivalence trials with a binary outcome. We assume 'all-or-none' compliance and independence between compliance and the outcome. Our results indicate that non-compliance does not always make it easier to demonstrate equivalence. The direction and magnitude of changes in the type I error rate and power of the study depend on the patterns of noncompliance, event probabilities, the margin of equivalence and other factors. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:1183 / 1199
页数:17
相关论文
共 50 条
  • [21] Identifying causal effects in experiments with spillovers and non-compliance
    DiTraglia, Francis J.
    Garcia-Jimeno, Camilo
    O'Keeffe-O'Donovan, Rossa
    Sanchez-Becerra, Alejandro
    JOURNAL OF ECONOMETRICS, 2023, 235 (02) : 1589 - 1624
  • [22] Covariate adjustment in clinical trials with non-ignorable missing data and non-compliance
    Levy, DE
    O'Malley, AJ
    Normand, SLT
    STATISTICS IN MEDICINE, 2004, 23 (15) : 2319 - 2339
  • [23] Correcting for non-compliance in randomized non-inferiority trials with active and placebo control using structural models
    Wu, Ying
    Zhao, Liang
    Hou, Yan
    Li, Kang
    Zhou, Xiaohua
    STATISTICS IN MEDICINE, 2015, 34 (06) : 950 - 965
  • [24] Estimation of treatment effects in randomised trials with non-compliance and a dichotomous outcome using structural mean models
    Robins, J
    Rotnitzky, A
    BIOMETRIKA, 2004, 91 (04) : 763 - 783
  • [25] Accounting for extent of non-compliance when estimating treatment effects on an ordinal outcome in randomized clinical trials
    Zhu, Junxian
    Li, Jialiang
    Richards, A. Mark
    Chan, Mark Y.
    Tai, Bee-Choo
    BMC MEDICAL RESEARCH METHODOLOGY, 2025, 25 (01)
  • [26] ANALYSIS OF CROSSOVER CLINICAL TRIAL IN THE PRESENCE OF NON-COMPLIANCE: A TWO-STAGE LATENT TREAT GRIZZLE MODEL
    Soltanian, Ali Reza
    Ahmadinia, Hassan
    Roshanaei, Ghodratollah
    JP JOURNAL OF BIOSTATISTICS, 2020, 17 (02) : 569 - 582
  • [27] Explanations for corporate governance non-compliance: A rhetorical analysis
    Shrives, Philip J.
    Brennan, Niamh M.
    CRITICAL PERSPECTIVES ON ACCOUNTING, 2017, 49 : 31 - 56
  • [28] Statistically Adjusting for Wear Time in Randomized Trials of Continuous Glucose Monitors as a Complement to Intent-to-Treat and As-Treated Analyses: Application and Evaluation in Two Trials
    Weinstein, Joshua M.
    Berkowitz, Seth A.
    Pratley, Richard E.
    Shah, Kushal S.
    Kahkoska, Anna R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (07) : 457 - 466
  • [29] A causal model for longitudinal randomised trials with time-dependent non-compliance
    Becque, Taeko
    White, Ian R.
    Haggard, Mark
    STATISTICS IN MEDICINE, 2015, 34 (12) : 2019 - 2034
  • [30] Analysis of non-compliance with smoke-free legislation in Russia
    Zasimova, Liudmila
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2019, 64 (03) : 413 - 422